Form4insider filings, from the source

SEC Form 4 · accession 0001182489-17-000033

Nexvet Biopharma plc · NVET

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Daniel J. Hirsch
10% Owner · Other
Period of report
Dec 31, 2016
Accepted (ET)
Jan 11, 2017 · 6:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.001 per shareF1,F2,F3,F4,F5,F6,F7,F8holding———0ISee Footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses